The Ministry of Health is phasing out some drugs containing valsartan to treat high blood pressure

The circular included a list of the medicines concerned, noting that the listed products are registered with the Drug Administration of the Ministry of Health and Community Protection and asking the agent to withdraw the products mentioned from the public and private sectors of the country. the health, . All health professionals should not describe and dispense with the above mentioned products, if any, and use the registered alternatives. Patients should not interrupt the use of the drug unless consulting a doctor to get rid of other alternatives registered with the department.

LABORATORIOS CINFA SA – Spain

LABORATORIOS CINFA SA – Spain

LABORATORIOS CINFA SA [Espagne19659004] LABORATORIOS CINFA SA [Espagne19659004] PHARMA INTERNATIONAL CO. – Jordan

VALDIO ™

GLOBALPHARMA The Sanofi CO. LLC – United Arab Emirates

VALDIO HCT

GLOBALPHARMA The Sanofi CO. LLC – UAE

Safety of Diovan Based on Novartis Contact with Manufacturer

The Ministry has confirmed that all drugs containing Valsartan, which are made with the same material from other sources, are intact. and not affected. He pointed to the receipt of an official letter from Novartis, which developed the drug, stating that its products containing Valsartan, specifically Diovan, Co-Diovan Entresto and Exforge, were not affected by the process of withdrawal because they do not use the active ingredient from an external supplier. The use of a different source of the active substance was manufactured at Novartis in Ireland and Switzerland. He said that Diovan is used to treat high blood pressure, which in turn causes cardiovascular disease, and that all existing diuretics are in the state and in the world.

Stopping disinformation treatment causes serious complications in patients

Circulation of rumors without obtaining official information has serious repercussions on society, causing patient uncertainty and fear of their safety, preventing them from taking medication or changing doses of drugs without consulting practitioners, reducing the patient's confidence Yeh used, and a negative effect on the credibility of health programs and drugs used in the UAE United Arab Emirates.

has drawn to its regular review random samples of drugs in the laboratory of quality control and complex research in Dubai technology and medical research. This explanation was due to poor information on the withdrawal of Diovan, via social media at the Gulf level, causing panic in patients and stopping the use of the drug, which affects their health.

Ministry communicates with global pharmaceutical agencies The Ministry of Health and Community Protection is in daily contact with the Food and Drug Administration and European and Australian medicines and, if a warning is given, immediately sends a circular to all health authorities concerned to remove and destroy them in order to preserve their health and safety.

She urged community members to consult with the Ministry of Health and the relevant health authorities to obtain official information on any medical problem, medication and medical warning concerning medicines and medical devices. If the public wants to confirm any health information on UAE registered health products and flyers, they can contact the Ministry of Health and Community Protection by email at [email protected] or via the telephone service. of Tamani or by telephone: 2301448 -04

– End –

For further information, please contact:

Orient Planet for Public Relations and Marketing

United Arab Emirates

Tel: 0097144562888

Fax: 0097144549528

E-mail: [email protected]

Website: www.orientplanet.com

© Press Release 2018